Abbott Labs trims profit forecast after revenue miss

(Reuters) - Medical device maker Abbott Laboratories fell just short of Wall Street estimates for quarterly revenue on Wednesday and trimmed the upper end of its full-year earnings forecast.The company's shares fell 3% in early trading, after having gained on Tuesday following Abbott's $3 billion (2.35 billion pounds)share repurchase announcement, as well as high expectations in the run-up to the results."High expectations are likely the root cause of the stock pressure," said Cowen and Co..